ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,131.60
0.64%
Dow Jones
40,287.53
-0.93%
Brent Oil
81.985
-0.36%
Bitcoin
67,086.68
-1.57%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Grifols SA (GRFS)

  7. Grifols SA (GRFS) News

GRFS

Grifols (GRFS)

Grifols SA
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GRFS
DateTimeSourceHeadlineSymbolCompany
07/03/20246:59AMIH Market NewsApple Joins OpenAI Board, Logitech President Opts Out of Reelection, and More NewsNASDAQ:GRFSGrifols SA
07/01/20246:00AMGlobeNewswire Inc.Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven yearsNASDAQ:GRFSGrifols SA
06/18/20247:30AMGlobeNewswire Inc.Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier GroupNASDAQ:GRFSGrifols SA
06/17/20244:20AMGlobeNewswire Inc.Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficienciesNASDAQ:GRFSGrifols SA
06/14/20245:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GRFSGrifols SA
06/04/202410:51AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GRFSGrifols SA
05/31/20244:46PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GRFSGrifols SA
04/19/20244:42PMPR Newswire (US)Grifols 2023 Annual Report on Form 20-F filed with the SECNASDAQ:GRFSGrifols SA
04/18/20249:30AMGlobeNewswire Inc.Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.NASDAQ:GRFSGrifols SA
04/15/20247:06AMIH Market NewsSamsung Surpasses Apple in Q1 Smartphone Market; Salesforce in Talks to Acquire Informatica, and More NewsNASDAQ:GRFSGrifols SA
04/04/20244:00AMGlobeNewswire Inc.Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus ScreeningNASDAQ:GRFSGrifols SA
03/22/20249:07AMIH Market NewsFedEx Soars 13% with Profits Above Forecasts, Nike Hit by China Slowdown, and Latest NewsNASDAQ:GRFSGrifols SA
03/08/20246:19AMIH Market NewsCNOOC Oil Field Discovery in South China Sea, Grifols Surges 18% After KPMG Approval, and Latest NewsNASDAQ:GRFSGrifols SA
02/14/20243:16AMGlobeNewswire Inc.Grifols announces positive topline phase 3 fibrinogen clinical trial resultsNASDAQ:GRFSGrifols SA
01/26/20245:14PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GRFSGrifols SA
01/16/20246:05AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GRFSGrifols SA
01/12/20246:10AMIH Market NewsWall Street Highlights: DocuSign Acquisition Battle, Tesla Berlin Production Halt, and MoreNASDAQ:GRFSGrifols SA
01/10/20241:08PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GRFSGrifols SA
01/10/20248:59AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GRFSGrifols SA
01/10/20246:21AMIH Market NewsWall Street Highlights: Tesla Launches Restyled Model 3, VinFast Unveils Pickup Prototype, and MoreNASDAQ:GRFSGrifols SA
01/09/20242:49PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GRFSGrifols SA
01/09/20248:25AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GRFSGrifols SA
12/29/20239:59AMDow Jones NewsGrifols Shares Rise on $1.76 Billion Sale of 20% Stake in Shanghai RAAS to Pay Down DebtNASDAQ:GRFSGrifols SA
12/29/20239:46AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GRFSGrifols SA
12/29/20239:40AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GRFSGrifols SA
11/16/20235:00AMPR Newswire (US)Grifols launches new solution to facilitate pre-transfusion compatibility testing in multiple myeloma patientsNASDAQ:GRFSGrifols SA
11/15/20238:00AMGlobeNewswire Inc.Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous Dosing Option for Patients with Alpha1-Antitrypsin DeficiencyNASDAQ:GRFSGrifols SA
11/06/20238:00AMGlobeNewswire Inc.GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023NASDAQ:GRFSGrifols SA
11/02/20231:25PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GRFSGrifols SA
10/24/20236:30PMGlobeNewswire Inc.Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer’s Vaccine at CTADNASDAQ:GRFSGrifols SA
 Showing the most relevant articles for your search:NASDAQ:GRFS

Your Recent History

NASDAQ
QBAK
Qualstar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved